499 related articles for article (PubMed ID: 14608017)
1. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
3. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
5. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
[TBL] [Abstract][Full Text] [Related]
6. Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts.
McElwee KJ; Boggess D; King LE; Sundberg JP
J Invest Dermatol; 1998 Nov; 111(5):797-803. PubMed ID: 9804341
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
[TBL] [Abstract][Full Text] [Related]
8. Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata.
Zöller M; McElwee KJ; Engel P; Hoffmann R
J Invest Dermatol; 2002 Jun; 118(6):983-92. PubMed ID: 12060392
[TBL] [Abstract][Full Text] [Related]
9. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice.
Freyschmidt-Paul P; McElwee KJ; Botchkarev V; Kissling S; Wenzel E; Sundberg JP; Happle R; Hoffmann R
J Investig Dermatol Symp Proc; 2003 Jun; 8(1):104-8. PubMed ID: 12895005
[TBL] [Abstract][Full Text] [Related]
10. Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model.
McElwee KJ; Freyschmidt-Paul P; Hoffmann R; Kissling S; Hummel S; Vitacolonna M; Zöller M
J Invest Dermatol; 2005 May; 124(5):947-57. PubMed ID: 15854035
[TBL] [Abstract][Full Text] [Related]
11. Alopecia areata versus juvenile alopecia in C3H/HeJ mice: tools to dissect the role of inflammation in focal alopecia.
McElwee KJ; Boggess D; King LE; Sundberg JP
Exp Dermatol; 1999 Aug; 8(4):354-5. PubMed ID: 10439272
[No Abstract] [Full Text] [Related]
12. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
[TBL] [Abstract][Full Text] [Related]
13. Induction of cellular immunity against hair follicle melanocyte causes alopecia.
Nagai H; Oniki S; Oka M; Horikawa T; Nishigori C
Arch Dermatol Res; 2006 Aug; 298(3):131-4. PubMed ID: 16786344
[TBL] [Abstract][Full Text] [Related]
14. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata.
Sato-Kawamura M; Aiba S; Tagami H
Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779
[TBL] [Abstract][Full Text] [Related]
15. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?
Paus R; Slominski A; Czarnetzki BM
Yale J Biol Med; 1993; 66(6):541-54. PubMed ID: 7716973
[TBL] [Abstract][Full Text] [Related]
16. Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata.
Zhang JG; Oliver RF
Br J Dermatol; 1994 Apr; 130(4):405-14. PubMed ID: 7910477
[TBL] [Abstract][Full Text] [Related]
17. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase.
Ito T; Hashizume H; Shimauchi T; Funakoshi A; Ito N; Fukamizu H; Takigawa M; Tokura Y
J Dermatol Sci; 2013 Feb; 69(2):140-7. PubMed ID: 23312578
[TBL] [Abstract][Full Text] [Related]
18. Alopecia areata in aging C3H/HeJ mice.
Sundberg JP; Cordy WR; King LE
J Invest Dermatol; 1994 Jun; 102(6):847-56. PubMed ID: 8006447
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss.
Tobin DJ; Sundberg JP; King LE; Boggess D; Bystryn JC
J Invest Dermatol; 1997 Sep; 109(3):329-33. PubMed ID: 9284100
[TBL] [Abstract][Full Text] [Related]
20. Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin.
Tang L; Cao L; Sundberg JP; Lui H; Shapiro J
Exp Dermatol; 2004 Jan; 13(1):5-10. PubMed ID: 15009110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
